Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Glucosinolate-rich broccoli microgreen extract promotes osteogenic differentiation and antioxidant responses in human stromal cells: implications for nutraceutical modulation of bone metabolism.

Gambari L., Amore E., Carpentieri S., Di Padua F., Dalle Carbonare LG., Cominacini M.

Laboratory Study on Chronic Inflammation, published in Food Funct (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Food Funct (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42429589
DOI
10.1039/d6fo02085b

Abstract (original English)

Over recent decades, interest in functional foods capable of mitigating age-related disorders and chronic inflammation-associated diseases has markedly increased. Among these, dietary organosulfur compounds, abundantly present in various vegetables, are recognized for their potential preventive effects against multiple pathological conditions. Isothiocyanates and glucosinolates (GLS) derived from Brassicaceae species, most notably sulforaphane and its precursor glucoraphanin, have demonstrated promising potential as adjunctive agents in the management of osteoporosis. Broccoli microgreens are especially rich in GLS; however, their potential application in osteoporosis prevention remains to be conclusively established. The present study sought to evaluate the bioactivity of a GLS-rich methanolic extract derived from broccoli microgreens cultivated under a vertical hydroponic system. Human adipose-derived stromal cells were used as in vitro model. Cellular viability was assessed through lactate dehydrogenase, Alamar blue, and neutral red uptake assays; expression of antioxidant genes was evaluated by real-time PCR. Osteogenic differentiation was investigated via Alizarin Red staining, alkaline phosphatase activity assays, and real-time PCR for osteogenic genes. Our findings indicate that broccoli microgreen extract did not exhibit any significant cytotoxicity up to 100 µM, exerte

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
BrassicaHumansGlucosinolatesPlant ExtractsOsteogenesisCell DifferentiationAntioxidantsStromal CellsDietary SupplementsCells, Cultured

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research